Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday that it has increased its quarterly dividend for the first quarter of 2023.
The company has reported an increase in quarterly dividend of 15% to USD1.13 per share on the outstanding common stock for the first quarter of 2023.
The dividend will be paid to shareholders of record at 15 February 2023 on 10 March 2023.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development